Madeleine Griswold Haff MD
Assistant Professor, Gastroenterology
85 E. Concord St | (617) 638-8000madeleine.haff@bmc.org
mghaff@bu.edu
Biography
Madeleine G. Haff, MD, is a physician in the Section of Gastroenterology at Boston Medical Center, and is an Assistant Professor at the Boston University School of Medicine. She serves as the Associate Program Director of the Gastroenterology and Hepatology Fellowship Program.
A graduate of Williams College, Dr. Haff received her MD from the Geisel School of Medicine at Dartmouth where she was the president of the Dartmouth chapter of the Alpha Omega Alpha honor society as well as a member of the Gold Humanism Honor Society. She completed her Internal Medicine Residency at Beth Israel Deaconess Hospital in Boston and her fellowship in Gastroenterology and Hepatology at Boston Medical Center (BMC). She is board certified in Internal Medicine and Gastroenterology. She is a member of American Association for the Study of Liver Diseases and the American College of Gastroenterology.
An attending physician in the section of Gastroenterology and Hepatology, Dr. Haff provides care to both those with general GI disorders as well as liver-specific disorders.
Her research focuses on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), care delivery, and predictive markers of disease. She has been involved and led several projects examining MASLD, cardiovascular risk, and predictors of disease in the Framingham Heart Study. She also serves as co-investigator on several clinical trials on chronic liver diseases.
Education
Medicine, MD, Geisel School of Medicine
Biology/French, BA, Williams College
Publications
El-Sabawi B, Tanriverdi K, Gajjar P, Nayor M, Landman JM, Below JE, Haff M, Long M, Ezpeleta M, Freedman JE, Varady K, Shah R, Perry AS. Circulating Proteomics Identifies a Dynamic Profile of Hepatic Steatosis During Metabolic Intervention. J Am Heart Assoc. 2025 May 20; 14(10):e037100. PMID: 40371575.
Published on 1/1/2025Florea VV, Gajjar P, Huang S, Tang J, Zhao S, Davenport M, Mi MY, Haff M, Zhang X, Miller PE, Vasan RS, Liu CT, Lewis GD, Shah RV, Long MT, Nayor M. Hepatic Steatosis and Fibrosis, Cardiorespiratory Fitness, and Metabolic Mediators in the Community. Liver Int. 2025 Jan; 45(1):e16147. PMID: 39673712.
Published on 7/20/2024Kumar S, Mohanty A, Mantry P, Schwartz RE, Haff M, Therapondos G, Noureddin M, Dieterich D, Girgrah N, Cohn K, Savanth M, Fuchs M. Deploying a metabolic dysfunction-associated steatohepatitis consensus care pathway: findings from an educational pilot in three health systems. BMC Prim Care. 2024 Jul 20; 25(1):265. PMID: 39033284.
Published on 5/9/2023Haff M.G., Mohanty, A. Role of nutrition in preventing liver disease. Current Hepatology Reports. 2023; (22):74-81.
Published on 4/1/2022Kronen RJ, Haff M, Patwardhan V, LaSalvia M. Improving hepatitis A vaccination rates in hospitalised patients with cirrhosis: insights and lessons learnt. BMJ Open Qual. 2022 Apr; 11(2). PMID: 35440438.
Published on 11/1/2019Porter ED, Trooboff SW, Haff MG, Cooros JC, Wolffing AB, Briggs A, Rhynhart KK, Crockett AO. Helmet use is associated with higher Injury Severity Scores in alpine skiers and snowboarders evaluated at a Level I trauma center. J Trauma Acute Care Surg. 2019 Nov; 87(5):1205-1213. PMID: 31335753.
Published on 1/15/2014Olive AJ, Haff MG, Emanuele MJ, Sack LM, Barker JR, Elledge SJ, Starnbach MN. Chlamydia trachomatis-induced alterations in the host cell proteome are required for intracellular growth. Cell Host Microbe. 2014 Jan 15; 15(1):113-24. PMID: 24439903.